New review sharpens focus on canine influenza at the interface: full analysis

A new review in Virology puts canine influenza virus, or CIV, back into the One Health spotlight, arguing that influenza in dogs deserves more systematic attention at the human-animal interface. The paper, scheduled for Volume 621, August 2026, frames CIV as a canine-adapted influenza A lineage with implications that extend beyond respiratory disease in dogs, particularly because of dogs’ close contact with people and their susceptibility to influenza viruses from multiple species. (sciencedirect.com)

The backdrop here is two decades of CIV evolution. Equine-origin H3N8 crossed into dogs in the late 1990s and became established in canine populations, while avian-origin H3N2 emerged in dogs in Asia and later spread to the U.S., where it was identified during the 2015 Chicago-area outbreak. More recent evolutionary work suggests H3N2 has now spent roughly 20 years adapting within dogs, with steady genetic change over that period. That history matters because influenza’s risk profile often changes gradually, through host adaptation and reassortment, rather than through a single dramatic event. (cdc.gov)

In the new review, the authors synthesize evidence that canine influenza adaptation involves several familiar influenza mechanisms: changes in receptor binding, neuraminidase stalk variation, polymerase mutations including PB2 E627K, I714S, and D701N, immune antagonism through non-structural proteins, and reassortment-driven diversification. Their central argument is that these changes can improve replication efficiency, transmissibility, and immune evasion in mammalian hosts. The paper’s highlighted concern is not that canine influenza is already causing human disease, but that dogs may function as potential “mixing vessels” for avian-, swine-, and human-origin influenza viruses under the right ecological conditions. (sciencedirect.com)

That concern is tempered by current public health evidence. CDC says canine influenza in dogs is currently associated with influenza A(H3N2), that there has not been a single reported human infection with a canine influenza virus anywhere in the world, and that its Influenza Risk Assessment Tool rated canine H3N2’s pandemic potential as low. Several veterinary and academic sources echo that there are no known human cases, even as they advise caution when handling dogs with respiratory disease and stress the importance of infection control in high-contact canine settings. (cdc.gov)

Industry and expert guidance remains practical rather than alarmist. AAHA’s canine vaccination guidelines classify canine influenza vaccine as noncore, meaning use should depend on exposure risk, geography, and lifestyle. Merck Veterinary Manual and university diagnostic programs continue to describe CIV as highly contagious among dogs, with most cases mild but some progressing to pneumonia, especially with secondary infections. That aligns with the operational reality many clinics already know: CIV is primarily a respiratory pathogen and outbreak-management problem in congregate dog populations, but one with enough evolutionary flexibility to justify ongoing surveillance. (aaha.org)

Why it matters: For veterinary teams, this review reinforces the importance of seeing canine influenza through both a clinical and population-health lens. On the clinical side, practices need solid triage, isolation, PPE, and client communication protocols for dogs with acute infectious respiratory signs. On the public health side, the review adds weight to calls for better host-based surveillance, sequencing, and data sharing, especially in shelters, referral hospitals, transport networks, and other environments where dogs from different backgrounds mix. For pet parents, the message isn’t that dog flu is becoming a human flu crisis. It’s that veterinary medicine sits at a key observation point for detecting influenza evolution early. (sciencedirect.com)

What to watch: The next signals to follow are whether surveillance programs expand, whether new reassortant or antigenically distinct CIV strains are reported, and whether vaccine recommendations shift in higher-risk canine populations. If canine H3N2 continues to diversify, veterinary diagnosticians and public health agencies will likely pay closer attention to sequence data, cross-species spillover experiments, and outbreak patterns in dense dog populations. (sciencedirect.com)